PLAY PODCASTS
Emerging Insights on Adverse Events During ART and Implications for Treatment
Episode 60

Emerging Insights on Adverse Events During ART and Implications for Treatment

Hear insights and answers to audience questions from Joseph J. Eron, Jr., MD, and Darcy Wooten, MD, on HIV ART safety and tolerability including recent data on weight gain and metabolic implications with INSTIs and NRTIs.

Decera Clinical Education Infectious Disease Podcast · Darcy Wooten MD, Joseph J. Eron Jr. MD

July 6, 202141m 4s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Joseph J. Eron, Jr., MD, and Darcy Wooten, MD, share insights on HIV antiretroviral therapy safety and tolerability including recent data on weight gain and metabolic implications with INSTIs and NRTIs as well as the latest updates and recommendations on dolutegravir and pregnancy.

Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Darcy Wooten, MD
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California

Content based on a CME program supported by independent educational grants from Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare

Link to full program:
https://bit.ly/3ydMtcL


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

nrti cardiovasculardtg weight gainabacavir cardiovascularcab safetycabotegravir safetycab tolerabilitycab weight gaintenofovir alafenamide weight gaindtg pregnancynrti weight gainintegrase inhibitors weight gaincabotegravir weight gainbictegravir weight gainnrtis weight gaininsti weight gaininsti diabetesart adverse eventsinstis weight gaindolutegravir weight gaintaf weight gaindolutegravir ntdcabotegravir tolerabilityinsti metabolic toxicitybic weight gaindolutegravir pregnancy